Collegium Pharmaceutical, Inc. (COLL)

NMS – Real Time Price. Currency in USD

35.69

-0.12 (-0.34%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

781M

631M

567M

464M

Cost of goods sold

-317M

-254M

-241M

-252M

Gross Profit

463M

377M

326M

212M

Operating expenses (excl. COGS)

-276M

-186M

-151M

-142M

Operating Income

187M

191M

175M

69M

Non-operating income, total

-94M

-93M

-100M

-98M

Pretax income

93M

99M

76M

-29M

Equity in earnings

Taxes

-30M

-29M

-28M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

63M

69M

48M

-25M

Collegium Pharmaceutical, Inc. (COLL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Collegium Pharmaceutical, Inc. (COLL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Collegium Pharmaceutical, Inc. (COLL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Collegium Pharmaceutical, Inc. (COLL)

Income Statement (Annual)

Income Statement (Annual)